0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trastuzumab Emtansine for Injection Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-21U10948
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Trastuzumab Emtansine for Injection Market Research Report 2022
BUY CHAPTERS

Global Trastuzumab Emtansine for Injection Market Research Report 2025

Code: QYRE-Auto-21U10948
Report
January 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Trastuzumab Emtansine for Injection Market Size

The global market for Trastuzumab Emtansine for Injection was valued at US$ 316 million in the year 2024 and is projected to reach a revised size of US$ 507 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Trastuzumab Emtansine for Injection Market

Trastuzumab Emtansine for Injection Market

Trastuzumab emtansine was first approved by the U.S. Food and Drug Administration (FDA) in February 2013 for the treatment of HER2-positive, metastatic breast cancer in patients who have previously received trastuzumab and a taxane chemotherapy.
Trastuzumab emtansine has demonstrated significant benefits in the treatment of HER2-positive breast cancer, including improved progression-free survival and overall survival compared to standard treatments. Additionally, its targeted approach minimizes damage to healthy cells, reducing some of the side effects typically associated with traditional chemotherapy.
However, like any medical treatment, trastuzumab emtansine may cause side effects, including potential cardiac toxicity, liver problems, and adverse effects on the nervous system. Patients receiving this therapy should be carefully monitored by healthcare professionals.
Overall, trastuzumab emtansine represents an important advancement in the management of HER2-positive breast cancer and has provided new treatment options for patients who have previously received trastuzumab and taxane-based chemotherapy. The drug continues to be studied in clinical trials to explore its potential in various treatment settings and other cancer types.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Trastuzumab Emtansine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Emtansine for Injection.
The Trastuzumab Emtansine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trastuzumab Emtansine for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trastuzumab Emtansine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Trastuzumab Emtansine for Injection Market Report

Report Metric Details
Report Name Trastuzumab Emtansine for Injection Market
Accounted market size in year US$ 316 million
Forecasted market size in 2031 US$ 507 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 60mg
  • 100mg
  • 150mg
  • 160mg
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genentech, Daiichi Sankyo, Amgen, Pfizer, Samsung Bioepis, Mylan(Viatris), Celltrion, Roche, Accord Healthcare, Nippon Kayaku, Chugai Pharmaceutical, Henlius, Orifarm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Trastuzumab Emtansine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Trastuzumab Emtansine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Trastuzumab Emtansine for Injection Market growing?

Ans: The Trastuzumab Emtansine for Injection Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Trastuzumab Emtansine for Injection Market size in 2031?

Ans: The Trastuzumab Emtansine for Injection Market size in 2031 will be US$ 507 million.

Who are the main players in the Trastuzumab Emtansine for Injection Market report?

Ans: The main players in the Trastuzumab Emtansine for Injection Market are Genentech, Daiichi Sankyo, Amgen, Pfizer, Samsung Bioepis, Mylan(Viatris), Celltrion, Roche, Accord Healthcare, Nippon Kayaku, Chugai Pharmaceutical, Henlius, Orifarm

What are the Application segmentation covered in the Trastuzumab Emtansine for Injection Market report?

Ans: The Applications covered in the Trastuzumab Emtansine for Injection Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Trastuzumab Emtansine for Injection Market report?

Ans: The Types covered in the Trastuzumab Emtansine for Injection Market report are 60mg, 100mg, 150mg, 160mg, Others

Recommended Reports

Cancer Drug Injections

Targeted Cancer Therapies

Immunotherapy & Advanced

1 Trastuzumab Emtansine for Injection Market Overview
1.1 Product Definition
1.2 Trastuzumab Emtansine for Injection by Type
1.2.1 Global Trastuzumab Emtansine for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 60mg
1.2.3 100mg
1.2.4 150mg
1.2.5 160mg
1.2.6 Others
1.3 Trastuzumab Emtansine for Injection by Application
1.3.1 Global Trastuzumab Emtansine for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Trastuzumab Emtansine for Injection Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Emtansine for Injection Revenue 2020-2031
1.4.2 Global Trastuzumab Emtansine for Injection Sales 2020-2031
1.4.3 Global Trastuzumab Emtansine for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Trastuzumab Emtansine for Injection Market Competition by Manufacturers
2.1 Global Trastuzumab Emtansine for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Trastuzumab Emtansine for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Trastuzumab Emtansine for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Trastuzumab Emtansine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Trastuzumab Emtansine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trastuzumab Emtansine for Injection, Product Type & Application
2.7 Global Key Manufacturers of Trastuzumab Emtansine for Injection, Date of Enter into This Industry
2.8 Global Trastuzumab Emtansine for Injection Market Competitive Situation and Trends
2.8.1 Global Trastuzumab Emtansine for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Trastuzumab Emtansine for Injection Players Market Share by Revenue
2.8.3 Global Trastuzumab Emtansine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Trastuzumab Emtansine for Injection Market Scenario by Region
3.1 Global Trastuzumab Emtansine for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Trastuzumab Emtansine for Injection Sales by Region: 2020-2031
3.2.1 Global Trastuzumab Emtansine for Injection Sales by Region: 2020-2025
3.2.2 Global Trastuzumab Emtansine for Injection Sales by Region: 2026-2031
3.3 Global Trastuzumab Emtansine for Injection Revenue by Region: 2020-2031
3.3.1 Global Trastuzumab Emtansine for Injection Revenue by Region: 2020-2025
3.3.2 Global Trastuzumab Emtansine for Injection Revenue by Region: 2026-2031
3.4 North America Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.4.1 North America Trastuzumab Emtansine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Trastuzumab Emtansine for Injection Sales by Country (2020-2031)
3.4.3 North America Trastuzumab Emtansine for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.5.1 Europe Trastuzumab Emtansine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Trastuzumab Emtansine for Injection Sales by Country (2020-2031)
3.5.3 Europe Trastuzumab Emtansine for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trastuzumab Emtansine for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Trastuzumab Emtansine for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Trastuzumab Emtansine for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Trastuzumab Emtansine for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.7.1 Latin America Trastuzumab Emtansine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Trastuzumab Emtansine for Injection Sales by Country (2020-2031)
3.7.3 Latin America Trastuzumab Emtansine for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Trastuzumab Emtansine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Trastuzumab Emtansine for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Trastuzumab Emtansine for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trastuzumab Emtansine for Injection Sales by Type (2020-2031)
4.1.1 Global Trastuzumab Emtansine for Injection Sales by Type (2020-2025)
4.1.2 Global Trastuzumab Emtansine for Injection Sales by Type (2026-2031)
4.1.3 Global Trastuzumab Emtansine for Injection Sales Market Share by Type (2020-2031)
4.2 Global Trastuzumab Emtansine for Injection Revenue by Type (2020-2031)
4.2.1 Global Trastuzumab Emtansine for Injection Revenue by Type (2020-2025)
4.2.2 Global Trastuzumab Emtansine for Injection Revenue by Type (2026-2031)
4.2.3 Global Trastuzumab Emtansine for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Trastuzumab Emtansine for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Trastuzumab Emtansine for Injection Sales by Application (2020-2031)
5.1.1 Global Trastuzumab Emtansine for Injection Sales by Application (2020-2025)
5.1.2 Global Trastuzumab Emtansine for Injection Sales by Application (2026-2031)
5.1.3 Global Trastuzumab Emtansine for Injection Sales Market Share by Application (2020-2031)
5.2 Global Trastuzumab Emtansine for Injection Revenue by Application (2020-2031)
5.2.1 Global Trastuzumab Emtansine for Injection Revenue by Application (2020-2025)
5.2.2 Global Trastuzumab Emtansine for Injection Revenue by Application (2026-2031)
5.2.3 Global Trastuzumab Emtansine for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Trastuzumab Emtansine for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genentech
6.1.1 Genentech Company Information
6.1.2 Genentech Description and Business Overview
6.1.3 Genentech Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genentech Trastuzumab Emtansine for Injection Product Portfolio
6.1.5 Genentech Recent Developments/Updates
6.2 Daiichi Sankyo
6.2.1 Daiichi Sankyo Company Information
6.2.2 Daiichi Sankyo Description and Business Overview
6.2.3 Daiichi Sankyo Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo Trastuzumab Emtansine for Injection Product Portfolio
6.2.5 Daiichi Sankyo Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Company Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Amgen Trastuzumab Emtansine for Injection Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Trastuzumab Emtansine for Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Samsung Bioepis
6.5.1 Samsung Bioepis Company Information
6.5.2 Samsung Bioepis Description and Business Overview
6.5.3 Samsung Bioepis Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Samsung Bioepis Trastuzumab Emtansine for Injection Product Portfolio
6.5.5 Samsung Bioepis Recent Developments/Updates
6.6 Mylan(Viatris)
6.6.1 Mylan(Viatris) Company Information
6.6.2 Mylan(Viatris) Description and Business Overview
6.6.3 Mylan(Viatris) Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan(Viatris) Trastuzumab Emtansine for Injection Product Portfolio
6.6.5 Mylan(Viatris) Recent Developments/Updates
6.7 Celltrion
6.7.1 Celltrion Company Information
6.7.2 Celltrion Description and Business Overview
6.7.3 Celltrion Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Celltrion Trastuzumab Emtansine for Injection Product Portfolio
6.7.5 Celltrion Recent Developments/Updates
6.8 Roche
6.8.1 Roche Company Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roche Trastuzumab Emtansine for Injection Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Accord Healthcare
6.9.1 Accord Healthcare Company Information
6.9.2 Accord Healthcare Description and Business Overview
6.9.3 Accord Healthcare Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Accord Healthcare Trastuzumab Emtansine for Injection Product Portfolio
6.9.5 Accord Healthcare Recent Developments/Updates
6.10 Nippon Kayaku
6.10.1 Nippon Kayaku Company Information
6.10.2 Nippon Kayaku Description and Business Overview
6.10.3 Nippon Kayaku Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nippon Kayaku Trastuzumab Emtansine for Injection Product Portfolio
6.10.5 Nippon Kayaku Recent Developments/Updates
6.11 Chugai Pharmaceutical
6.11.1 Chugai Pharmaceutical Company Information
6.11.2 Chugai Pharmaceutical Description and Business Overview
6.11.3 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product Portfolio
6.11.5 Chugai Pharmaceutical Recent Developments/Updates
6.12 Henlius
6.12.1 Henlius Company Information
6.12.2 Henlius Description and Business Overview
6.12.3 Henlius Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Henlius Trastuzumab Emtansine for Injection Product Portfolio
6.12.5 Henlius Recent Developments/Updates
6.13 Orifarm
6.13.1 Orifarm Company Information
6.13.2 Orifarm Description and Business Overview
6.13.3 Orifarm Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Orifarm Trastuzumab Emtansine for Injection Product Portfolio
6.13.5 Orifarm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trastuzumab Emtansine for Injection Industry Chain Analysis
7.2 Trastuzumab Emtansine for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trastuzumab Emtansine for Injection Production Mode & Process Analysis
7.4 Trastuzumab Emtansine for Injection Sales and Marketing
7.4.1 Trastuzumab Emtansine for Injection Sales Channels
7.4.2 Trastuzumab Emtansine for Injection Distributors
7.5 Trastuzumab Emtansine for Injection Customer Analysis
8 Trastuzumab Emtansine for Injection Market Dynamics
8.1 Trastuzumab Emtansine for Injection Industry Trends
8.2 Trastuzumab Emtansine for Injection Market Drivers
8.3 Trastuzumab Emtansine for Injection Market Challenges
8.4 Trastuzumab Emtansine for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Trastuzumab Emtansine for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Trastuzumab Emtansine for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Trastuzumab Emtansine for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Trastuzumab Emtansine for Injection Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Trastuzumab Emtansine for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Trastuzumab Emtansine for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Trastuzumab Emtansine for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Trastuzumab Emtansine for Injection Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Trastuzumab Emtansine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Trastuzumab Emtansine for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Trastuzumab Emtansine for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Trastuzumab Emtansine for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Trastuzumab Emtansine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Emtansine for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Trastuzumab Emtansine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Trastuzumab Emtansine for Injection Sales by Region (2020-2025) & (K L)
 Table 18. Global Trastuzumab Emtansine for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Trastuzumab Emtansine for Injection Sales by Region (2026-2031) & (K L)
 Table 20. Global Trastuzumab Emtansine for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Trastuzumab Emtansine for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Trastuzumab Emtansine for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Trastuzumab Emtansine for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Trastuzumab Emtansine for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Trastuzumab Emtansine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Trastuzumab Emtansine for Injection Sales by Country (2020-2025) & (K L)
 Table 27. North America Trastuzumab Emtansine for Injection Sales by Country (2026-2031) & (K L)
 Table 28. North America Trastuzumab Emtansine for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Trastuzumab Emtansine for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Trastuzumab Emtansine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Trastuzumab Emtansine for Injection Sales by Country (2020-2025) & (K L)
 Table 32. Europe Trastuzumab Emtansine for Injection Sales by Country (2026-2031) & (K L)
 Table 33. Europe Trastuzumab Emtansine for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Trastuzumab Emtansine for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Trastuzumab Emtansine for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Trastuzumab Emtansine for Injection Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Trastuzumab Emtansine for Injection Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Trastuzumab Emtansine for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Trastuzumab Emtansine for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Trastuzumab Emtansine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Trastuzumab Emtansine for Injection Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Trastuzumab Emtansine for Injection Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Trastuzumab Emtansine for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Trastuzumab Emtansine for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Trastuzumab Emtansine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Trastuzumab Emtansine for Injection Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Trastuzumab Emtansine for Injection Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Trastuzumab Emtansine for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Trastuzumab Emtansine for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Trastuzumab Emtansine for Injection Sales (K L) by Type (2020-2025)
 Table 51. Global Trastuzumab Emtansine for Injection Sales (K L) by Type (2026-2031)
 Table 52. Global Trastuzumab Emtansine for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Trastuzumab Emtansine for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Trastuzumab Emtansine for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Trastuzumab Emtansine for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Trastuzumab Emtansine for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Trastuzumab Emtansine for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Trastuzumab Emtansine for Injection Price (US$/L) by Type (2020-2025)
 Table 59. Global Trastuzumab Emtansine for Injection Price (US$/L) by Type (2026-2031)
 Table 60. Global Trastuzumab Emtansine for Injection Sales (K L) by Application (2020-2025)
 Table 61. Global Trastuzumab Emtansine for Injection Sales (K L) by Application (2026-2031)
 Table 62. Global Trastuzumab Emtansine for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Trastuzumab Emtansine for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Trastuzumab Emtansine for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Trastuzumab Emtansine for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Trastuzumab Emtansine for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Trastuzumab Emtansine for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Trastuzumab Emtansine for Injection Price (US$/L) by Application (2020-2025)
 Table 69. Global Trastuzumab Emtansine for Injection Price (US$/L) by Application (2026-2031)
 Table 70. Genentech Company Information
 Table 71. Genentech Description and Business Overview
 Table 72. Genentech Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Genentech Trastuzumab Emtansine for Injection Product
 Table 74. Genentech Recent Developments/Updates
 Table 75. Daiichi Sankyo Company Information
 Table 76. Daiichi Sankyo Description and Business Overview
 Table 77. Daiichi Sankyo Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Daiichi Sankyo Trastuzumab Emtansine for Injection Product
 Table 79. Daiichi Sankyo Recent Developments/Updates
 Table 80. Amgen Company Information
 Table 81. Amgen Description and Business Overview
 Table 82. Amgen Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. Amgen Trastuzumab Emtansine for Injection Product
 Table 84. Amgen Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. Pfizer Trastuzumab Emtansine for Injection Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Samsung Bioepis Company Information
 Table 91. Samsung Bioepis Description and Business Overview
 Table 92. Samsung Bioepis Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 93. Samsung Bioepis Trastuzumab Emtansine for Injection Product
 Table 94. Samsung Bioepis Recent Developments/Updates
 Table 95. Mylan(Viatris) Company Information
 Table 96. Mylan(Viatris) Description and Business Overview
 Table 97. Mylan(Viatris) Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 98. Mylan(Viatris) Trastuzumab Emtansine for Injection Product
 Table 99. Mylan(Viatris) Recent Developments/Updates
 Table 100. Celltrion Company Information
 Table 101. Celltrion Description and Business Overview
 Table 102. Celltrion Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 103. Celltrion Trastuzumab Emtansine for Injection Product
 Table 104. Celltrion Recent Developments/Updates
 Table 105. Roche Company Information
 Table 106. Roche Description and Business Overview
 Table 107. Roche Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 108. Roche Trastuzumab Emtansine for Injection Product
 Table 109. Roche Recent Developments/Updates
 Table 110. Accord Healthcare Company Information
 Table 111. Accord Healthcare Description and Business Overview
 Table 112. Accord Healthcare Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 113. Accord Healthcare Trastuzumab Emtansine for Injection Product
 Table 114. Accord Healthcare Recent Developments/Updates
 Table 115. Nippon Kayaku Company Information
 Table 116. Nippon Kayaku Description and Business Overview
 Table 117. Nippon Kayaku Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 118. Nippon Kayaku Trastuzumab Emtansine for Injection Product
 Table 119. Nippon Kayaku Recent Developments/Updates
 Table 120. Chugai Pharmaceutical Company Information
 Table 121. Chugai Pharmaceutical Description and Business Overview
 Table 122. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 123. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product
 Table 124. Chugai Pharmaceutical Recent Developments/Updates
 Table 125. Henlius Company Information
 Table 126. Henlius Description and Business Overview
 Table 127. Henlius Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 128. Henlius Trastuzumab Emtansine for Injection Product
 Table 129. Henlius Recent Developments/Updates
 Table 130. Orifarm Company Information
 Table 131. Orifarm Description and Business Overview
 Table 132. Orifarm Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 133. Orifarm Trastuzumab Emtansine for Injection Product
 Table 134. Orifarm Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Trastuzumab Emtansine for Injection Distributors List
 Table 138. Trastuzumab Emtansine for Injection Customers List
 Table 139. Trastuzumab Emtansine for Injection Market Trends
 Table 140. Trastuzumab Emtansine for Injection Market Drivers
 Table 141. Trastuzumab Emtansine for Injection Market Challenges
 Table 142. Trastuzumab Emtansine for Injection Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Trastuzumab Emtansine for Injection
 Figure 2. Global Trastuzumab Emtansine for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Trastuzumab Emtansine for Injection Market Share by Type: 2024 & 2031
 Figure 4. 60mg Product Picture
 Figure 5. 100mg Product Picture
 Figure 6. 150mg Product Picture
 Figure 7. 160mg Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Trastuzumab Emtansine for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Trastuzumab Emtansine for Injection Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Clinics
 Figure 13. Others
 Figure 14. Global Trastuzumab Emtansine for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Trastuzumab Emtansine for Injection Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Trastuzumab Emtansine for Injection Sales (2020-2031) & (K L)
 Figure 17. Global Trastuzumab Emtansine for Injection Average Price (US$/L) & (2020-2031)
 Figure 18. Trastuzumab Emtansine for Injection Report Years Considered
 Figure 19. Trastuzumab Emtansine for Injection Sales Share by Manufacturers in 2024
 Figure 20. Global Trastuzumab Emtansine for Injection Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Trastuzumab Emtansine for Injection Players: Market Share by Revenue in Trastuzumab Emtansine for Injection in 2024
 Figure 22. Trastuzumab Emtansine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Trastuzumab Emtansine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Trastuzumab Emtansine for Injection Sales Market Share by Country (2020-2031)
 Figure 25. North America Trastuzumab Emtansine for Injection Revenue Market Share by Country (2020-2031)
 Figure 26. United States Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Trastuzumab Emtansine for Injection Sales Market Share by Country (2020-2031)
 Figure 29. Europe Trastuzumab Emtansine for Injection Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Trastuzumab Emtansine for Injection Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Trastuzumab Emtansine for Injection Revenue Market Share by Region (2020-2031)
 Figure 37. China Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Trastuzumab Emtansine for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Trastuzumab Emtansine for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Trastuzumab Emtansine for Injection Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Trastuzumab Emtansine for Injection Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Trastuzumab Emtansine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Trastuzumab Emtansine for Injection by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Trastuzumab Emtansine for Injection by Type (2020-2031)
 Figure 58. Global Trastuzumab Emtansine for Injection Price (US$/L) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Trastuzumab Emtansine for Injection by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Trastuzumab Emtansine for Injection by Application (2020-2031)
 Figure 61. Global Trastuzumab Emtansine for Injection Price (US$/L) by Application (2020-2031)
 Figure 62. Trastuzumab Emtansine for Injection Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS